RxDoctor Payments Data

Victoria Dilts, PA

Physician Assistant · Sioux Falls, SDNPI 1609651959

Payments from drug & device makers

What this record shows

Medtronic accounts for 63.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $2,168 and has fallen 76.8% since, to $503 in 2025. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,429in general payments, 2019–2025

Across 46 payments — averaging $74.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Johnson & Johnson$375
  • Teleflex LLC$346
  • Bayer$143
  • Boston Scientific$109
  • Dendreon Pharmaceuticals LLC$52
  • plus $217 from 10 others

What the payments were for

  • Travel & lodging$1,76852%
  • Food & beverage$1,66248%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,429 in reported general payments places this provider in the 90th percentile of 548 physician assistant providers in South Dakota.

See all physician assistant providers in South Dakota

Medicare billing

Part B allowed, 2024
$73,537
Medicare patients
425
Services billed
2,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron164$112,626
MyrbetriqMirabegron128$77,848
Estradiol70$10,048
Methenamine Hippurate133$6,899
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst113$1,901
Fosfomycin Tromethamine11$1,649
Desmopressin Acetate30$1,283
Cephalexin121$610
Tamsulosin Hcl58$378
Oxybutynin Chloride ErOxybutynin Chloride15$221
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim34$72
Tramadol Hcl55$54
Fluconazole11$44
Ciprofloxacin Hcl16$43

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$40$112,626164 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 548 physician assistant providers in South Dakota.

Other physician assistant in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →